Get your Emails warmed up and ready to send

Build sender reputation and reach more inboxes with automated email warmup.

Warm up your emails

Starting at $49/month

Start Warming Up

Robert Lu

SVP of Technical Operations @Frontera Therapeutics

Burlington, MA, US
EMAILS
r••••••••@fronteratherapeutics.com
MOBILE NUMBERS
+16•••••••81

Signup · Get unlimited contacts

WORK HISTORY

Jan 2020 — Present

SVP of Technical Operations @Frontera Therapeutics

Boston, MA, US

Founding employee; supported $35M Series A and $160M Series B financing, and growing the company from 1 to 130+ employees.• Built and led cross-functional teams including 20+ PD/AD scientists and 70+ manufacturing staff.• Led 6 IND submissions in the U.S. and China.• Oversaw global tech transfers to CDMOs and internal GMP facilities.• Directed process development, scale-up, and GMP manufacturing for clinical-stage viral vector programs.• Led the design/buildout of a sq ft R&D lab (U.S.) and a sq ft GMP facility (China).• Delivered 8 GMP lots during COVID under the challenging supply and scheduling constraints. • Contributed to corporate strategy as a member of the senior leadership team.

EDUCATION

N/A

Brown University

Ph.D., Chemisty

N/A

Peking University

BS, Biology

N/A

Brown University

Doctor of Philosophy - PhD

SKILLS

BiotechnologyCellGmpTechnology TransferCell CultureProtein ChemistryPharmaceutical IndustryCell Line DevelopmentBiopharmaceuticalsLife SciencesProcess DevelopmentBiochemistryDnaMonoclonal AntibodiesAssay DevelopmentMolecular BiologyProcess SimulationTransfectionCmc Regulatory Affairs

ABOUT ROBERT LU

Accomplished biopharmaceutical executive with over 20 years of leadership in CMC strategy, process development, GMP manufacturing, and regulatory affairs across multiple therapeutic modalities, including monoclonal antibodies, recombinant proteins, gene therapies, and other complex biologics. Proven track record of leading global teams, advancing programs from preclinical through commercial stages, and successfully navigating IND filings, late-stage development, post-approval activities, and global regulatory submissions.Experienced in both U.S. and China operations, including GMP facility design and buildout, CDMO management, and global tech transfer. Recognized for driving technical excellence and operational efficiency in both early-stage biotech and big pharma.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.